Arkolith/Insider Trading/SQZ/Form 4

Schulman Amy W

Director, 10% OwnerSQZ Biotechnologies Co (SQZ) · full profile →Form 4 · filed Dec 15, 2021
Net Buying
Open-Market Buys
$40K
Open-Market Sells
$0
Net Open-Market Flow
$40K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2021Buy(P)2K$10.88$20K2K
Dec 13, 2021Buy(P)2K$10.94$20K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-069790) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML